![Gram-negative bacteria / Pseudomonadales / Aminoglycoside antibiotics / Food and Drug Administration / Tobramycin / Cystic fibrosis / Pseudomonas aeruginosa / Center for Drug Evaluation and Research / Novartis / Health / Microbiology / Medicine Gram-negative bacteria / Pseudomonadales / Aminoglycoside antibiotics / Food and Drug Administration / Tobramycin / Cystic fibrosis / Pseudomonas aeruginosa / Center for Drug Evaluation and Research / Novartis / Health / Microbiology / Medicine](https://www.pdfsearch.io/img/ecbf698cce6f8fd044789ea91052ec7f.jpg) Gram-negative bacteria Pseudomonadales Aminoglycoside antibiotics Food and Drug Administration Tobramycin Cystic fibrosis Pseudomonas aeruginosa Center for Drug Evaluation and Research Novartis Health Microbiology Medicine | | Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anti-Infective Drugs Advisory Committee Meeting September 5, 2012 Location: The FDA White Oak Campus, Building 31, The Great RooAdd to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 159,99 KBShare Document on Facebook
|